Cortical Excitability and Role of rTMS in Cannabis Use Disorder

Status

UNKNOWN

Phases

Early Phase 1

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT04106336

Enrollment

Registered

2019-09-27

Start date

2019-10-01

Completion date

2020-12-30

Last updated

2019-09-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cannabis Use Disorder, Moderate

Brief summary

Repetitive transcranial magnetic stimulation (rTMS) and cortical excitability have a role in cannabis use disorder

Interventions

DEVICErTMS

Repetitive transcranial magnetic stimulation (rTMS) will be done for cannabis addict

Study design

Allocation

NON_RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

MALE

Age

18 Years to 50 Years

Healthy volunteers

Yes

Inclusion criteria

* 18to 50 years of age * cannabis use disorder according to DSM 5 definition * clear consent to participate in study

Exclusion criteria

* cardiac peacemaker * metal implant in the head as participate will be applied to magnetic field of TMS * current intake of any medication affect cognition (as anti psychotic and anti epileptic) * current history of neurological , psychiatric or general medical disease .current or previous drug (other than cannabis )or alcohol abuse or participation in another trial during the past 8 weeks . * age younger than 18 and older than 50 years

Design outcomes

Primary

Measure	Time frame	Description
Determination of role of rTMS for reducing cannabis craving	1 year	Incidenc of cannabis craving after rTMS

Secondary

Measure	Time frame	Description
Estimation of cortical excitability in cannabis addict	1 year	Incidence of cannabis craving after cortical excitability

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026